GSK to Test Experimental Drug to Treat Pneumonia From COVID-19 GSK to Test Experimental Drug to Treat Pneumonia From COVID-19
GlaxoSmithKline will start trials of an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 at the end of the month.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: Arthritis | COVID-19 | Infectious Diseases | Intensive Care | Pneumonia | Rheumatoid Arthritis | Rheumatology